Interesting Image

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging Appearance of Gastrointestinal Behcet’s Disease


  • Burak İnce
  • Ali Kibar
  • Sertaç Asa
  • Rabia Lebriz Uslu Beşli
  • Muhammet Sait Sağer
  • Ahmet Emre Eşkazan
  • Ali İbrahim Hatemi
  • Gülen Hatemi
  • Kerim Sönmezoğlu

Received Date: 11.11.2020 Accepted Date: 17.01.2021 Mol Imaging Radionucl Ther 2022;31(1):57-59 PMID: 35114753

Behcet’s syndrome (BS) is a variable vessel vasculitis with multi-organ involvement. Recurrent episodes of oral and genital ulcers, papulopustular and erythema nodosum-like skin lesions, and arthritis are relatively more frequent, whereas uveitis, venous and arterial lesions, nervous system, and gastrointestinal involvement are less common, but are severe manifestations. The frequency of gastrointestinal involvement shows important variation between countries as more common in the Far East and the United States, and much less common in Turkey and the Middle East. The main clinical signs of gastrointestinal Behcet’s disease include abdominal pain, diarrhea, blood in the stool, fever, and weight loss. Ulcers seen in the terminal ileum, cecum, and ascending colon are common endoscopic findings. Herein, we presented the positron emission tomography/magnetic resonance imaging findings of gastrointestinal involvement in BS.

Keywords: Gastrointestinal Behcet’s disease, Behcet syndrome, myelodysplastic syndromes, monosomy 7, acute myeloid leukemia, 18F-FDG, PET scan, MRI


Informed Consent: Was obtained from the patient.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions

Concept: M.S.S., R.L.U.B., S.A., Design: M.S.S., R.L.U.B., K.S., Data Collection or Processing: B.İ., A.K., S.A., Literature Search: B.İ., A.K., S.A., Writing: B.İ., A.K., R.L.U.B., A.E.E., A.İ.H., G.H.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.


  1. Yazici H, Seyahi E, Hatemi G, Yazici Y. Behçet syndrome: a contemporary view. Nat Rev Rheumatol 2018;14:107-119. Erratum in: Nat Rev Rheumatol 2018;14:119.
  2. Lopalco G, Rigante D, Venerito V, Fabiani C, Franceschini R, Barone M, Lapadula G, Galeazzi M, Frediani B, Iannone F, Cantarini L. Update on the medical management of gastrointestinal Behçet’s disease. In Mediators of Inflammation 2017. doi: 10.1155/2017/1460491.
  3. Hatemi I, Hatemi G, Çelik AF. Gastrointestinal Involvement in Behçet Disease. Rheum Dis Clin North Am 2018;44:45-64.
  4. Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS, Bang D. Colonoscopic findings in intestinal Behçet’s disease. Inflammatory Bowel Diseases 2001;7:243-249.
  5. Lee HJ, Cheon JH. Optimal diagnosis and disease activity monitoring of intestinal Behçet’s disease. Intest Res 2017;15:311-317.
  6. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis 2018;77:808-818.
  7. Yilmaz U, Ar MC, Esatoglu SN, Bavunoglu I, Erzin YZ, Hatemi AI, Yildirim S, Hatemi G, Celik AF. How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review. Ann Hematol 2020;99:1193-1203.
  8. Matsumoto Y, Ota K, Yamada H. Gastrointestinal: intestinal Behçet’s disease-like ulcers associated with myelodysplastic syndrome with monosomy 7. J Gastroenterol Hepatol 2019;34:310.